Profit and Prudence: Navigating Psychedelic Commercialization Through Lessons from the Prescription Opioid Crisis

Daniel Eisenkraft Klein

Health Policy, 2023, vol. 138, issue C

Abstract: •Psychedelics show significant promise for a number of mental health issues.•There are immense pressures on policymakers to cater to commercial psychedelic interests.•Decisionmakers should take lessons from failures that led to the opioid crisis.•Psychedelics are one useful tool in a broader mental health policy approach.•Policymakers should be wary of industry-promoted messaging of psychedelics as panaceas.

Date: 2023
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0168851023002191
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:138:y:2023:i:c:s0168851023002191

DOI: 10.1016/j.healthpol.2023.104934

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().